232 related articles for article (PubMed ID: 8438471)
1. Synergistic effect of cholera toxin with cyclosporine and azathioprine on survival of rat renal allografts.
Asano T; Murai M; Nakamura H
Transplant Proc; 1993 Feb; 25(1 Pt 1):761-2. PubMed ID: 8438471
[TBL] [Abstract][Full Text] [Related]
2. Prolongation of rat renal allograft survival by the synergistic effects of azathioprine and cholera toxin.
Asano T; Murai M; Nakamura H
Transplant Proc; 1992 Aug; 24(4):1409-10. PubMed ID: 1496600
[No Abstract] [Full Text] [Related]
3. FTY720, a novel immunosuppressant possessing unique mechanisms. II. Long-term graft survival induction in rat heterotopic cardiac allografts and synergistic effect in combination with cyclosporine A.
Hoshino Y; Suzuki C; Ohtsuki M; Masubuchi Y; Amano Y; Chiba K
Transplant Proc; 1996 Apr; 28(2):1060-1. PubMed ID: 8623226
[No Abstract] [Full Text] [Related]
4. The interaction of cyclosporin A with other immunosuppressive agents in dog recipients of renal allografts.
Homan WP; French ME; Fabre JW; Millard PR; Denton TG; Morris PJ
Transplant Proc; 1980 Jun; 12(2):287-90. PubMed ID: 6994297
[No Abstract] [Full Text] [Related]
5. Immunosuppressive effects of FK 506 on rat renal allograft survival, in comparison with cyclosporine.
Jiang H; Fujitsu T; Sakuma S; Ogawa T; Tamura K; Fujii Y; Akiyama Y; Izumi S; Takahara S; Ishibashi M
Transplant Proc; 1995 Feb; 27(1):367-9. PubMed ID: 7533413
[No Abstract] [Full Text] [Related]
6. Biological characteristics of a novel immunosuppressant, IR-1116, specific for B lymphocytes.
Matsumoto S; Marui S; Shiho O; Tsukamoto K; Yoshimura N; Oka T
Transplant Proc; 1993 Feb; 25(1 Pt 1):734-7. PubMed ID: 8382385
[No Abstract] [Full Text] [Related]
7. Synergistic activity of the triple combination: cyclosporine, rapamycin, and brequinar.
Stepkowski SM; Kahan BD
Transplant Proc; 1993 Jun; 25(3 Suppl 2):29-31. PubMed ID: 8516939
[No Abstract] [Full Text] [Related]
8. Synergistic prolongation of renal allograft survival with cyclosporine and rapamycin.
Robertson A; Plenter R; Francis DM; Clunie GJ
Transplant Proc; 1993 Oct; 25(5):2898-9. PubMed ID: 8212279
[No Abstract] [Full Text] [Related]
9. A novel immunomodulator KRP-203 combined with cyclosporine prolonged graft survival and abrogated transplant vasculopathy in rat heart allografts.
Takahashi M; Shimizu H; Murakami T; Enosawa S; Suzuki C; Takeno Y; Hakamata Y; Kudou S; Izawa S; Yasue T; Kobayashi E
Transplant Proc; 2005; 37(1):143-5. PubMed ID: 15808575
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil, azathioprine and cyclophosphamide enhanced efficacy combined with cyclosporine in rat cardiac transplantation.
Ostraat O; Qi Z; Olausson M; Tufveson G; Ekberg H
Scand J Immunol; 1997 Apr; 45(4):343-8. PubMed ID: 9105419
[TBL] [Abstract][Full Text] [Related]
11. Leflunomide prolongs pulmonary allograft and xenograft survival.
Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
[TBL] [Abstract][Full Text] [Related]
12. Acute skin graft rejection can be prevented and treated in rat models by malononitrilamides.
Schorlemmer HU; Schwab W; Ruuth E; Kurrle R
Transplant Proc; 1996 Dec; 28(6):3048-50. PubMed ID: 8962182
[No Abstract] [Full Text] [Related]
13. Selectin inhibitor bimosiamose prolongs survival of kidney allografts by reduction in intragraft production of cytokines and chemokines.
Langer R; Wang M; Stepkowski SM; Hancock WW; Han R; Li P; Feng L; Kirken RA; Berens KL; Dupre B; Podder H; Dixon RA; Kahan BD
J Am Soc Nephrol; 2004 Nov; 15(11):2893-901. PubMed ID: 15504942
[TBL] [Abstract][Full Text] [Related]
14. The effect of cyclosporin A on experimental pancreas allografts in the rat.
Garvey JF; McShane P; Poole MD; Millard PR; Morris PJ
Transplant Proc; 1980 Jun; 12(2):266-9. PubMed ID: 6771902
[No Abstract] [Full Text] [Related]
15. 1 alpha,25-Dihydroxycholecalciferol reduces rejection and improves survival in rat liver allografts.
Redaelli CA; Wagner M; Tien YH; Mazzucchelli L; Stahel PF; Schilling MK; Dufour JF
Hepatology; 2001 Nov; 34(5):926-34. PubMed ID: 11679963
[TBL] [Abstract][Full Text] [Related]
16. Effects of cholera toxin in xenograft survival.
Sakakibara N; Tsuru S; Shinomiya N; Click RE; Hirata K; Jamieson SW
Transplant Proc; 1993 Feb; 25(1 Pt 1):423-4. PubMed ID: 8438363
[No Abstract] [Full Text] [Related]
17. FTY720, a novel immunosuppressant possessing unique mechanisms. I. Prolongation of skin allograft survival and synergistic effect in combination with cyclosporine in rats.
Chiba K; Hoshino Y; Suzuki C; Masubuchi Y; Yanagawa Y; Ohtsuki M; Sasaki S; Fujita T
Transplant Proc; 1996 Apr; 28(2):1056-9. PubMed ID: 8623225
[No Abstract] [Full Text] [Related]
18. The effect of the prostaglandin analogues misoprostil and enisoprost on the synergy between donor-specific transfusion and cyclosporine in allograft survival.
Cofer BR; Davies CB; Alexander JW; Tchervenkov JI
Transplantation; 1992 Nov; 54(5):941-3. PubMed ID: 1440866
[No Abstract] [Full Text] [Related]
19. Short-term immunosuppression after rat parathyroid allotransplantation.
Timm S; Otto C; Begrich D; Illert B; Hamelmann W; Ulrichs K; Thiede A; Timmermann W
Microsurgery; 2003; 23(5):503-7. PubMed ID: 14558011
[TBL] [Abstract][Full Text] [Related]
20. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]